COHANCE LIFESCIENCES
Back to Income Statement
|
COHANCE LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹268 Cr | ₹300 Cr | ₹411 Cr | ₹454 Cr | ₹362 Cr |
What is the latest Consolidated Net Profit of COHANCE LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹268 Cr |
| Mar2024 | ₹300 Cr |
| Mar2023 | ₹411 Cr |
| Mar2022 | ₹454 Cr |
| Mar2021 | ₹362 Cr |
How is Consolidated Net Profit of COHANCE LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹268 Cr | -10.79 | |
| Mar2024 | ₹300 Cr | -26.99 | |
| Mar2023 | ₹411 Cr | -9.37 | |
| Mar2022 | ₹454 Cr | 25.24 | |
| Mar2021 | ₹362 Cr | - | |
Compare Consolidated Net Profit of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,262.4 Cr | -1.1% | -6% | -58.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -1.1% |
-6% |
-58.9% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses